Crossmark

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Crossref DOI link: https://doi.org/10.1186/s12943-018-0864-3

Published Online: 2018-08-23

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yi, Ming

Jiao, Dechao

Xu, Hanxiao

Liu, Qian

Zhao, Weiheng

Han, Xinwei

Wu, Kongming https://orcid.org/0000-0003-2499-1032
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81572608)

National Natural Science Foundation of China (81172422)

Wuhan Science and Technology Bureau (2017060201010170)

National High Technology Research and Development Program of China (2015AA020301)
License Information

Text and Data Mining valid from 2018-08-23
More Information

Article History

Received: 8 April 2018

Accepted: 24 July 2018

First Online: 23 August 2018

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.